Updated recommendations on the use of COVID-19 convalescent plasma, neutralizing antibodies and remarks on remdesivir now available in IDSA's COVID-19 Treatment and Management Guideline.

“Today’s announcement by FDA and CDC to temporarily pause the administration of the Johnson & Johnson COVID-19 vaccine is an indication that our safety monitoring system is working." Read More.

President Biden’s first proposed budget plan released today sends an encouraging message of intent to strengthen our nation’s health infrastructure, renew our standing as global leaders against infectious diseases and make our powerful resources equitably accessible to all Americans.

Our colleagues are committed to blazing trails in the field of infectious diseases. Fellowship in IDSA honors members who have worked tirelessly to achieve professional excellence through significant service to the field in clinical practice, research, administration or education.

The HIV Medicine Association and the Infectious Diseases Society of America applaud the introduction of legislation on Friday by Rep. Lisa Blunt Rochester (D-AL) to address the critical shortage of clinicians and dentists caring for people with HIV

In response to member feedback, IDSA has launched a print opt-out option for all members that receive biweekly issues of The Journal of Infectious Diseases in hard copy. Members that prefer not to receive JID in print may now receive their regular issues in electronic-only format.